FDA to lift warnings on menopause hormone therapy, potentially boosting access
From The Washington Post:
The Food and Drug Administration will no longer require warnings on hormone replacement therapies that some doctors say have long prevented women from taking medications aimed at treating the symptoms of menopause.
Since 2003, the drugs for menopausal women have included a black box warning stating that they may increase the risk of heart attacks, strokes, blood clots and certain cancers.
The impetus for the black box labels, the strongest safety warning the agency can give a medication, came after the early results of a national health study known as the Women’s Health Initiative, funded by the National Institutes of Health. But the scientific evidence behind the warning has shifted over the past two decades.
Image: JHVEPhoto